BioAgilytix
UKEntry
2021
Hold
5yr
Status
Active
Who owns BioAgilytix?
BioAgilytix is currently owned by Cinven through Cinven Seventh Fund (2019 vintage), since 2021. Across its history, BioAgilytix has been through 4 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
CinvenCinven Seventh Fund · 2019 · Buyout
4 ownership periods · full history below
Key facts
HQUK
SectorBiotech
Key takeaways
- ·Co-held by Cobepa and Cinven since 2018.
- ·Average hold across 2 realized cycles: 3 years.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Co-invest · 4 holders · 2018 · present
CobepaActive
2018 · present(8yr) · Cobepa · 2004 · Evergreen
Caledonia InvestmentsExited 2021
2019 · 2021(2yr) · Caledonia Private Capital · 2003 · Evergreen
Trade Sale · to
MOIC
–
CinvenActive
2021 · present(5yr) · Cinven Seventh Fund · 2019 · Buyout
More from Cinven Seventh Fund
Other portfolio companies in the same fund.
Italy
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack BioAgilytix
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy BioAgilytix?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on BioAgilytix.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue